P3 Health Partners Inc (PIII) - Net Assets
Based on the latest financial reports, P3 Health Partners Inc (PIII) has net assets worth $73.19 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($654.39 Million) and total liabilities ($581.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PIII PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $73.19 Million |
| % of Total Assets | 11.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | -106.79% |
| 10-Year Change | N/A |
| Growth Volatility | 65.02 |
P3 Health Partners Inc - Net Assets Trend (2019–2025)
This chart illustrates how P3 Health Partners Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see PIII company net worth.
Annual Net Assets for P3 Health Partners Inc (2019–2025)
The table below shows the annual net assets of P3 Health Partners Inc from 2019 to 2025. Also explore P3 Health Partners Inc (PIII) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-140.24 Million | -193.78% |
| 2024-12-31 | $149.53 Million | -65.52% |
| 2023-12-31 | $433.66 Million | -17.03% |
| 2022-12-31 | $522.66 Million | -74.68% |
| 2021-12-31 | $2.06 Billion | +1685.17% |
| 2020-12-31 | $-130.22 Million | -132.81% |
| 2019-12-31 | $-55.93 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to P3 Health Partners Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 56597328400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $495.91 Million | % |
| Total Equity | $-155.23 Million | 100.00% |
P3 Health Partners Inc Competitors by Market Cap
The table below lists competitors of P3 Health Partners Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HCT Co. Ltd
KQ:072990
|
$30.83 Million |
|
Mahindra EPC Irrigation Limited
NSE:MAHEPC
|
$30.83 Million |
|
Microbix Biosystems Inc.
TO:MBX
|
$30.83 Million |
|
Avante Logixx Inc
V:XX
|
$30.84 Million |
|
Leon Fuat Bhd
KLSE:5232
|
$30.82 Million |
|
Manx Financial Group PLC
F:3IM
|
$30.82 Million |
|
Taya Inv-L
TA:TAYA
|
$30.81 Million |
|
Union Community Co. Ltd
KQ:203450
|
$30.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in P3 Health Partners Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 75,936,000 to -155,232,000, a change of -231,168,000 (-304.4%).
- Net loss of 147,948,000 reduced equity.
- Other factors decreased equity by 83,220,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-147.95 Million | -95.31% |
| Other Changes | $-83.22 Million | -53.61% |
| Total Change | $- | -304.42% |
Book Value vs Market Value Analysis
This analysis compares P3 Health Partners Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-88.37 | $7.88 | x |
| 2020-12-31 | $-164.70 | $7.88 | x |
| 2021-12-31 | $49.64 | $7.88 | x |
| 2022-12-31 | $7.04 | $7.88 | x |
| 2023-12-31 | $74.89 | $7.88 | x |
| 2024-12-31 | $25.83 | $7.88 | x |
| 2025-12-31 | $-47.49 | $7.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently P3 Health Partners Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -10.14%
- • Asset Turnover: 2.22x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-805.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -28.85% | 2.22x | 0.00x | $-37.77 Million |
| 2020 | 0.00% | -6.40% | 4.61x | 0.00x | $-18.39 Million |
| 2022 | -4614.40% | -25.74% | 1.20x | 149.77x | $-270.71 Million |
| 2023 | -40.65% | -4.56% | 1.47x | 6.06x | $-71.99 Million |
| 2024 | -178.90% | -9.05% | 1.92x | 10.32x | $-143.44 Million |
| 2025 | 0.00% | -10.14% | 2.22x | 0.00x | $-132.42 Million |
Industry Comparison
This section compares P3 Health Partners Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $603,309,672
- Average return on equity (ROE) among peers: -3.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| P3 Health Partners Inc (PIII) | $73.19 Million | 0.00% | 7.94x | $30.83 Million |
| Acadia Healthcare Company Inc (ACHC) | $2.90 Billion | 9.42% | 0.72x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $706.69 Million | 8.85% | 0.45x | $1.69 Billion |
| agilon health Inc (AGL) | $-232.03 Million | 0.00% | 0.00x | $1.50 Billion |
| Airsculpt Technologies Inc (AIRS) | $87.71 Million | -13.30% | 1.14x | $165.82 Million |
| Amedisys Inc (AMED) | $1.11 Billion | 10.72% | 0.79x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $170.84 Million | -71.51% | 1.28x | $624.22 Million |
| American Shared Hospital Service (AMS) | $15.99 Million | 6.89% | 1.80x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.05 Billion | 17.99% | 3.63x | $1.53 Billion |
| Astrana Health Inc (ASTH) | $-17.74K | 0.00% | 0.00x | $1.70 Billion |
About P3 Health Partners Inc
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.